Insights from the 2014 American College of Rheumatology Reproductive Health Summit
Lupus Foundation of America supported study demonstrates that blocking STAT5 reduces the production of CD154 by half.
Adolescent-onset lupus has worse prognosis and increased risk of lupus-related kidney disease and death.
Study funded by the Foundation's National Lupus Research Program secures NIH planning grant to develop a multi-center trial of mesenchymal stem cells.
Flare rates among participants receiving a low dose of the b-cell blocker did not meet primary endpoint but were lower for individuals receiving a higher dose.
An international group of lupus experts has developed a set of recommendations to implement the treat-to-target strategy for managing lupus.
Additional data from the CDC National Lupus Patient Registry project demonstrates that lupus is a widespread disease with a significant impact.
New research published in Lupus Science & Medicine looks at the potential association between vitamin D deficiency and heightened cardiovascular risk in children and teens with lupus.